Background: Surgeons provide patients with information before surgery, although standards of information are lacking and practice varies. The development and use of a 'core information set' as baseline information before surgery may improve understanding. A core set is a minimum set of information to use in all consultations before a specific procedure. This study developed a core information set for oesophageal cancer surgery.
Introduction
The mainstay of curative treatment for oesophageal cancer is surgery, which may be combined with neoadjuvant chemotherapy or chemoradiotherapy. Although many advances in surgery for oesophageal cancer have occurred over the past decade, long-term outcomes are generally poor and perioperative risks remain high 1 . The risk of in-hospital death after oesophagectomy is between 2 and 4 per cent, with serious complications occurring in about 20 per cent of patients. Surgery also has an immediate major detrimental impact on health-related quality of life. The 5-year survival rate after surgery is in the region of 30-50 per cent and health-related quality of life deficits persist in long-term survivors 2 -4 . The decision to undergo this surgery, therefore, is difficult. It is informed by discussion between surgeons and patients about short-term risks and long-term outcomes. It includes consideration of tumour stage, patient co-morbidities, and surgeon and patient preferences. It is now widely accepted that decision-making between surgeons and patients should be shared, with an exchange of information 5, 6 . Although there is an emphasis for surgeons to provide high-quality information to inform decisions, the actual information provided in consultations is largely unknown; standards for information provision and methods for informed consent for surgery are limited 7 . Indeed, the driver behind many consultations focuses on the medicolegal requirements for surgeons to discuss inherent risks of surgery rather than focus on patient information needs 8 -10 . Recent surveys in oesophagogastric cancer and other cancer sites have examined patients' preferences for information 8, 10 . Generally patients prefer more rather than less information. Patients want surgeons to raise sensitive issues (such as prognosis) in consultations rather than having to request this information themselves 8 -11 . The amount of information that could be communicated before surgery, however, is large and it is unclear what information is critical to inform understanding. There may also be a danger of overwhelming patients with data, which may reduce understanding 12 . One method for focused provision of information before surgery is to identify a 'core information (disclosure) set' for a specific procedure 13 . Core information represents the minimum information to be given by a clinician in all consultations for a particular operation. The idea of the core information set was described over 30 years ago when 'core disclosure' was recommended. It was suggested that a core disclosure set would include information of importance to key stakeholders (patients and surgeons) and be feasible to communicate in a regular clinical consultation. Although a seminal idea, it has received little attention 14 .
This study sought to develop a core information set for surgeons to use in consultations with patients before surgery for oesophageal cancer, and consider how it might be used to improve shared decision-making and informed consent.
Methods
Development of the core set involved three phases. Phase 1 generated an exhaustive list of all the information that could be communicated before surgery for oesophageal cancer. This long list was reduced by grouping similar pieces of information together and these were used to create questionnaire items. In phase 2 the questionnaire was used to survey stakeholders' views of the importance of each item using Delphi methods. Phase 3 finalized the core information set to be considered feasible for use in routine practice, through separate consensus meetings with surgeons and patients ( Table 1) .
Phase 1: questionnaire generation
Several sources were used to identify all possible pieces of information including: systematic searches of the international clinical and patient-reported outcome literature, analyses of written patient information leaflets used for oesophageal cancer surgery in UK hospitals, analyses of audio-recorded consultations between patients and surgeons when consent for surgery was discussed, and analyses of interviews with patients before surgery 15 -19 . Duplicates were removed and a long list of information created. Clinical items were categorized independently by two members of the study team into domains (for example, 30-and 90-day mortality were within the 'mortality' domain). Patient-reported outcomes were grouped into domains (for instance, ability to walk and activity levels were within the physical function domain), and verified Prioritization of information by key stakeholders Stakeholders are surveyed and asked to prioritize each piece of information Results of the survey are fed back to stakeholders in a second survey (Delphi methods) and they are asked to reprioritize each piece of information Data are analysed by the research group using predefined criteria to reduce the list of information This process produces two information lists (from patients and health professionals) ready for phase 3 Phase 3
Stakeholder consensus meetings The items are presented to each group and anonymized voting rates items as 'in', 'out' or 'unsure' Items rated as 'unsure' are discussed and more voting is undertaken This process produces two sets (1 selected by patients, 1 by professionals). These are compared and condensed into one core information set by two researchers and a patient representative 15 . Items from patient information leaflets were categorized independently by an experienced surgical trainee and a cancer nurse specialist. Discrepancies were resolved by discussion with the study lead. Overlapping domains between data sources were condensed to produce a final list of domains. Questionnaire items were created from the final domains using lay language with medical terminology in parentheses. This allowed stakeholder groups to rate items from 1 to 9, where 1 was considered 'not essential' and 9 'absolutely essential' information. The questionnaire was piloted by four members of a patient support group for face validity, understanding and acceptability. Following this, modifications were made. The questionnaire was translated into Dutch by a professional translator and checked by members of the study team.
Phase 2: Delphi consensus methods
Delphi methods were used to inform consensus on the core information set 20 . The questionnaire developed in phase 1 was sent to key stakeholders, including upper gastrointestinal and thoracic consultant surgeons and senior surgical trainees, clinical nurse specialists and patients who were awaiting or who had undergone surgery for oesophageal cancer (round 1). Surgeons and nurses were identified through a meeting of the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, and by personal knowledge of surgeons in oesophageal cancer surgery centres. Patients were recruited from Bristol and Birmingham in the UK, and from Amsterdam in the Netherlands. In the UK, participants were approached by post and responders agreeing to participate were sent the questionnaire with a stamp addressed envelope. One reminder was posted to patients if necessary. Health professionals were approached in a similar way with an e-mail reminder if required. In the Netherlands, participants were contacted by telephone and those agreeing to participate received postal questionnaires. Health professionals were contacted by e-mail and then posted questionnaires. First round questionnaires were analysed and participants sent a second questionnaire (round 2) which contained a reduced number of items. In round 2, participants were asked to reprioritize each item. Round 2 questionnaires also contained feedback from round 1. All questionnaires contained the individual's scores and group feedback (summarized as a mean score in order to be readily understood by participants). Participants were asked to rescore each item between 1 and 9. Questionnaires were reanalysed to determine which items should be retained and presented in the consensus meetings. The round 2 survey was carried out using retained items. Values in parentheses are percentages unless indicated otherwise; *values are mean (range). There were no differences between UK and Dutch patients' views in round 1 or 2. n.a., Not applicable.
Phase 3: face-to-face consensus meetings
Two consensus meetings were held. The first involved health professionals only and the second patients and carers, the latter being included in recognition of their crucial role in decision-making. The meetings were held in January and March 2013 respectively. All attendees were from the UK, and had completed the questionnaire surveys and responded to an invitation to attend a consensus meeting. Retained items from the second survey were presented and participants asked to anonymously rate their importance. Anonymized keypad voting took place whereby participants were asked to select 'in', 'out' or 'unsure' for each item. Histograms and descriptive statistics were created for each item during the meeting and displayed to the participants. Where there were apparent bimodal distributions with similar numbers of participants voting 'in' or 'out', further discussion to understand the underlying reasons took place followed by a further vote.
Sample size
In the absence of agreed methods to set a sample size for Delphi consensus meetings, an opportunistic approach was used with the aim of obtaining at least 100 respondents for each group for the survey and a group (less than 30) in which discussion could take place for the consensus meetings.
Data analysis
In round 1 of the survey, items were categorized as 'essential' and retained for round 2 if they were rated between 7 and 9 by over 50 per cent of respondents and between 1 and 3 by less than 15 per cent. Items not meeting these criteria were discarded. Mean scores were calculated for each retained item. The process of discarding items was performed separately for patient and health professional groups. Round 2 responses were analysed with stricter cut-off criteria, retaining items rated between 7 and 9 by over 70 per cent of respondents, and between 1 and 3 by less than 15 per cent. In the absence of agreed methods for selecting cut-off criteria within Delphi studies, these criteria were selected after discussion within the writing group and collaborators. Items retained after round 2 were considered in phase 3 consensus meetings, where each item was discussed and voting carried out as described above. All items retained from both meetings were included in the final core set.
Results

Phase 1
Review of all data sources describing information relating to oesophageal cancer surgery generated 901 individual pieces of information, which were categorized into 67 items within the round 1 questionnaire. These covered items about immediate and in-hospital surgical complications, longer-term side-effects, perioperative processes and experiences, longer-term quality of life, and cancer survival and related events (such as local and distant recurrence).
Phase 2
In round 1 of the Delphi survey, response rates were 76⋅5 per cent (185 of 242) for patients and 54⋅8 per cent (126 of 230) for health professionals. The majority of patients and health professionals were men (75⋅1 and 72⋅2 per cent respectively) ( Table 2 ). In the health professional group, 84 (67⋅7 per cent) were consultant surgeons, 29 (23⋅0 per cent) nurse specialists and 13 (10⋅4 per cent) were trainees; 98 (77⋅8 per cent) were from the UK. Forty of the surgeons (48 per cent) had been a consultant for more than 10 years, with 28 (33 per cent) working as a consultant for more than 5 years and 16 (19 per cent) for less than 5 years. Similar demographics were observed in patients from the UK and the Netherlands. In round 1, health professionals rated information about short-term clinical risks (anastomotic leakage, in-hospital mortality and inoperability) most highly, whereas long-term outcomes (such as information about survival and disease recurrence) were rated highest by the patient group ( Table 3) . By the time of the round 2 survey, 11 patients had died and 145 of 174 patient questionnaires were returned (response rate 83⋅3 per cent). The response rate for health professionals in round 2 was U n s u r e I n R etain item C a n c e r r e c u r r e n c e 1 5 1 2 1 3 3 3 U n s u r e I n R etain 'overall survival'* A n a s t o m o t i c l e a k 1 2 1 1 2 2 5 5 U n s u r e U n s u r e R etain 'in-hospital complications' † L o n g -t e r m q u a l i t y o f l i f e 1 6 1 1 1 0 2 7 I n U n s u r e R etain item I n -h o s p i t a l r e c o v e r y 1 6 1 0 0 2 3 6 I n U n s u r e R etain 'recovery milestones' † R e c o v e r y a f t e r d i s c h a r g e 1 1 1 0 0 0 8 8 U n s u r e U n s u r e R etain 'recovery after discharge' * Information about risks related to co-morbidities Retain 'recovery after discharge'* *Item retained and merged with another item; †item retained and merged with at least two items. HCP, healthcare professional; n.a., not applicable as not retained following Delphi survey.
84⋅9 per cent (107 of 126). Demographics of patient and professional participants were similar in rounds 1 and 2. Provision of group feedback and application of the more stringent cut-off criteria in round 2 resulted in 20 items being retained for the patient group and 22 items for the professional group. There were 15 overlapping items between groups.
Phase 3 consensus meetings
The two consensus meetings were attended by 18 professionals and 16 patients with seven carers respectively. In the initial anonymized voting at the professionals' meeting five items were voted 'in', eight 'out' and nine 'unsure'. In the patients' meeting it was five 'in', three 'out' and 12 'unsure' ( Table 4) . Extensive discussion in both meetings disclosed that items sometimes overlapped in content and meaning. Where appropriate, therefore, items were merged to form a single item. For example, it was agreed that items about 'cancer recurrence' and 'survival' should be combined as a Table 5 Final core information set of eight items
Experience on admission and in hospital Expected in-hospital experiences and milestones to recovery (including length of stay and pain control) Chances of inoperability Information about major complications (reoperation, leak, respiratory problems) In-hospital death Experience after discharge Expected recovery milestones after discharge and follow-up Impact on eating and drinking in the longer term Long-term overall quality of life Long-term survival single item 'overall survival'. Similarly, items about morbidity (reoperation, anastomotic leak and respiratory morbidity) were combined as 'in-hospital complications'. In both meetings, where items were initially voted 'unsure' further discussion and further voting took place ( Table 4) . There were two items for which the stakeholder groups had opposing views: experiences on admission and information about hospital stay. The groups agreed that these were overlapping, and so they were combined and retained in the final core set. After both stakeholder meetings the two core sets were combined. The final core information set of eight items is presented in a logical sequence in Table 5 .
Discussion
A core information set for surgeons to disclose in consultations with patients undergoing oesophageal cancer surgery has been developed that includes items of importance to both parties. It reflects a detailed scrutiny of the literature and written hospital information leaflets, as well as in-depth analysis of current practice and interviews with patients. The final items were selected by an iterative consensus process involving the views of over 250 health professionals and patients. The core set contains information about processes before surgery and during hospital admission, short-term risks and clinical outcomes.
It includes items about long-term quality of life and survival. It is recommended that surgeons and specialist nurses should use this information set during consultations with patients before surgery. This should then encourage discussion relevant to each patient's information needs, and clarify where patients want expanded details related to their disease and treatment.
The concept of provision of core information for surgery is not new, and there are other approaches for uniform information provision and for improving consultations and consent. Patient decision aids are designed to help people in situations in which there are alternative treatments available and where there are data from high-quality randomized trials describing the different treatments 20 . The purpose and use of decision aids therefore differs from that of a core information set because of the focus on considering treatment alternatives. There are also aids available for communicating information about risks and supporting patients before preoperative consultations 7, 21, 22 . These could be useful in the delivery of a core information set. Although a core information set is recommended as a minimum information provision, this can be supplemented with additional information of importance to patients or surgeons. For instance, including evidence-based data concerning a specific information item, such as institutional in-hospital mortality rate, is likely to be informative. In the context of oesophageal cancer, core information sets might also be developed that pertain to non-surgical treatment options.
Although this work has been conducted carefully, with participation from national and international key stakeholder groups, there are some methodological limitations.
Consensus was obtained by surveys and meetings that may not have appealed to a full range of stakeholders. It is possible that non-participants may value information differently from participants (the response rate for health professionals in the first survey round was 54⋅8 per cent), and a limited number of international health professionals was surveyed which may influence generalizability. As patients in this study were recruited from a variety of sources, it was not possible to gain detailed information on the final pathological tumour stage raising the possibility that patients with knowledge of advanced disease stages may respond to the survey differently from those with early-stage disease.
This work focused on preoperative information provision, although the patients surveyed had often undergone surgery. The views of patients after surgery may differ from those in the preoperative setting, although this issue has been addressed partly in previous work 23 . In the present study, patients and health professionals were specifically asked to prioritize information to be received after surgery. It showed that patients wanted information about whether the cancer had been removed (and cured), about eating and drinking, and subsequent recovery and possible complications. Both the present analysis and this previous work 23 from the Netherlands highlight the importance of provision of information about long-term survival and quality of life; these are things of key importance to patients that can be difficult to discuss in consultations, because many patients have a poor prognosis.
The present work represents a first step in this area. It is now necessary to develop the best methods to communicate this information in daily practice. Surgeons are familiar with talking about technical data related to surgery and short-term risks, and are trained to talk about a diagnosis of cancer. Imparting sensitive information about prognosis, however, is more difficult and doing this well also requires training. Adjuncts to information provision, such as graphical presentation of survival data, or information about quality-of-life outcomes, could be used to make this task easier and more easily understood by patients 21, 22, 24, 25 . It is also possible that the core information set could be communicated by different personnel (surgeons and nurses), as seems appropriate in the context of a particular healthcare system. Hospital written information leaflets could be modified to contain the core information set. This would at least ensure uniform information provision from all sources to help patients gain sufficient understanding to undergo surgery for oesophageal cancer.
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